JP2016523260A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016523260A5 JP2016523260A5 JP2016521898A JP2016521898A JP2016523260A5 JP 2016523260 A5 JP2016523260 A5 JP 2016523260A5 JP 2016521898 A JP2016521898 A JP 2016521898A JP 2016521898 A JP2016521898 A JP 2016521898A JP 2016523260 A5 JP2016523260 A5 JP 2016523260A5
- Authority
- JP
- Japan
- Prior art keywords
- pruritus
- serlopitant
- octahydroisoindol
- cyclopent
- polymorph
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361838784P | 2013-06-24 | 2013-06-24 | |
| US61/838,784 | 2013-06-24 | ||
| US13/925,509 | 2013-06-24 | ||
| US13/925,509 US8906951B1 (en) | 2013-06-24 | 2013-06-24 | Use of NK-1 receptor antagonists in pruritus |
| PCT/US2014/043811 WO2014209962A1 (en) | 2013-06-24 | 2014-06-24 | Use of nk-1 receptor antagonist serlopitant in pruritus |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019087897A Division JP2019142960A (ja) | 2013-06-24 | 2019-05-07 | そう痒におけるｎｋ−１受容体アンタゴニストのセルロピタントの使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016523260A JP2016523260A (ja) | 2016-08-08 |
| JP2016523260A5 true JP2016523260A5 (enrdf_load_html_response) | 2017-08-03 |
Family
ID=51230173
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016521898A Ceased JP2016523260A (ja) | 2013-06-24 | 2014-06-24 | そう痒におけるｎｋ−１受容体アンタゴニストのセルロピタントの使用 |
| JP2019087897A Pending JP2019142960A (ja) | 2013-06-24 | 2019-05-07 | そう痒におけるｎｋ−１受容体アンタゴニストのセルロピタントの使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019087897A Pending JP2019142960A (ja) | 2013-06-24 | 2019-05-07 | そう痒におけるｎｋ−１受容体アンタゴニストのセルロピタントの使用 |
Country Status (13)
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8906951B1 (en) | 2013-06-24 | 2014-12-09 | Tigercat Pharma, Inc. | Use of NK-1 receptor antagonists in pruritus |
| US9198898B2 (en) | 2013-06-24 | 2015-12-01 | Tigercat Pharma, Inc. | Use of NK-1 receptor antagonists in pruritus |
| CN106852118A (zh) | 2014-09-19 | 2017-06-13 | 赫伦治疗有限公司 | 阿瑞吡坦乳剂制剂 |
| JP6891385B2 (ja) | 2015-03-04 | 2021-06-18 | バンダ・ファーマシューティカルズ・インコーポレイテッドＶａｎｄａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． | トラジピタントによる治療方法 |
| US9974742B2 (en) | 2016-02-01 | 2018-05-22 | Heron Therapeutics, Inc. | Emulsion formulations of an NK-1 receptor antagonist and uses thereof |
| EP3411013A1 (en) * | 2016-02-01 | 2018-12-12 | Heron Therapeutics, Inc. | Emulsion comprising an nk-1 receptor antagonist |
| BR112018077300A2 (pt) * | 2016-06-29 | 2019-04-02 | Menlo Therapeutics Inc. | uso de antagonistas de neurocinina-1 para tratar diversas condições pruríticas |
| CA3073998A1 (en) * | 2017-09-13 | 2019-03-21 | Vanda Pharmaceuticals Inc. | Improved treatment of atopic dermatitis with tradipitant |
| CN111886025A (zh) * | 2017-11-01 | 2020-11-03 | 新加坡国立大学 | 血清素能药物治疗病毒诱发的血小板减少症的用途 |
| AU2019213835B2 (en) * | 2018-01-31 | 2024-12-19 | Twi Biotechnology, Inc. | Topical formulations comprising tofacitinib |
| CN115015440B (zh) * | 2022-07-08 | 2024-10-15 | 江苏杜瑞制药有限公司 | 一种生物样品中纳呋拉啡的检测方法 |
| CN117503699A (zh) * | 2023-12-08 | 2024-02-06 | 斯坦德医药研发(江苏)有限公司 | 阿瑞匹坦口服液制剂及制剂制造方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030100565A1 (en) | 2001-09-21 | 2003-05-29 | Boehringer Ingelheim International Gmbh | Method for the treatment or prevention of atopic dermatitis |
| CN100582093C (zh) * | 2004-01-27 | 2010-01-20 | 默克公司 | 氢异二氢吲哚速激肽受体拮抗剂 |
| TWI341198B (en) | 2004-01-27 | 2011-05-01 | Merck Sharp & Dohme | Hydroisoindoline tachykinin receptor antagonists |
| CA2612844A1 (en) | 2005-07-11 | 2007-01-18 | Merck & Co., Inc. | Process for making hydroisoindoline tachykinin receptor antagonists |
| AU2006302562A1 (en) | 2005-10-04 | 2007-04-19 | Merck Sharp & Dohme Corp. | Combination therapy for the treatment of urinary frequency, urinary urgency and urinary incontinence |
| WO2007146224A2 (en) | 2006-06-12 | 2007-12-21 | Merck & Co., Inc. | Combination therapy for the treatment of urinary frequency, urinary urgency and urinary incontinence |
| CA2662435A1 (en) | 2006-09-06 | 2008-03-13 | Merck & Co., Inc. | Liquid and semi-solid pharmaceutical formulations for oral administration of a substituted amide |
| US20090270477A1 (en) | 2006-11-02 | 2009-10-29 | Kuethe Jeffrey T | Polymorphs of a hydroisoindoline tachykinin receptor antagonist |
| AU2008233232A1 (en) | 2007-03-29 | 2008-10-09 | Merck Sharp & Dohme Corp. | Combination therapy for the treatment-of lower urinary tract symptoms |
| RU2370265C1 (ru) * | 2008-03-04 | 2009-10-20 | Лев Давидович Раснецов | Гель, обладающий противовоспалительным и противоаллергическим действием |
-
2014
- 2014-06-24 HK HK16111172.9A patent/HK1223820A1/zh unknown
- 2014-06-24 RU RU2015154037A patent/RU2666219C2/ru active
- 2014-06-24 EP EP14744671.0A patent/EP3013336A1/en not_active Withdrawn
- 2014-06-24 BR BR112015031724A patent/BR112015031724A2/pt not_active Application Discontinuation
- 2014-06-24 MX MX2015017763A patent/MX366728B/es active IP Right Grant
- 2014-06-24 AU AU2014302694A patent/AU2014302694B2/en not_active Ceased
- 2014-06-24 CA CA2915474A patent/CA2915474A1/en not_active Abandoned
- 2014-06-24 WO PCT/US2014/043811 patent/WO2014209962A1/en active Application Filing
- 2014-06-24 JP JP2016521898A patent/JP2016523260A/ja not_active Ceased
- 2014-06-24 KR KR1020157035921A patent/KR20160023692A/ko not_active Ceased
- 2014-06-24 CN CN201480035219.3A patent/CN105473138A/zh active Pending
-
2015
- 2015-12-14 PH PH12015502777A patent/PH12015502777A1/en unknown
- 2015-12-17 IL IL243189A patent/IL243189A0/en unknown
- 2015-12-18 MX MX2019008643A patent/MX2019008643A/es unknown
-
2019
- 2019-05-07 JP JP2019087897A patent/JP2019142960A/ja active Pending
-
2020
- 2020-01-14 AU AU2020200259A patent/AU2020200259A1/en not_active Abandoned
- 2020-02-04 PH PH12020500255A patent/PH12020500255A1/en unknown